2009 2012 T-CELL LYMPHOMAS: WORK IN PROGRESS Bologna, Royal Hotel Carlton, September 17-19, 2012 Honorary President: Sante Tura Presidents: Michele Baccarani, Stefano Pileri, Pier Luigi Zinzani FINAL PROGRAM Monday September 17, 2012 2.30 p.m. Welcome and Introduction State of the art on T-cell lymphomas Chairmen: M. Baccarani, F. Pane 2.45 p.m. WHO classification E.S. Jaffe 3.05 p.m. 3.25 p.m. 3.45 p.m. 4.05 p.m. 4.25 p.m. 4.45 p.m. 5.05 p.m. 5.25 p.m. Epidemiology: in western countries J.M. Vose in Asia Y.L. Kwong Conventional treatment of: Chairmen: S. Pileri, P.L. Zinzani PTCL S.M. Horwitz CTCL R. Willemze AITL R. Advani ALCL C. Gisselbrecht NK/T-cell lymphoma R. Suzuki Adult T-cell leukemia-lymphoma M. Ogura 5.45 p.m. Role of PET in T-cell lymphoma and T-cell specific response criteria B. Cheson 6.05 p.m. Effusion-associated ALCL of the breast - H.M. Prince 6.25 p.m. Epigenetic pharmacology and biology of new drugs O.A. O Connor
Tuesday September 18, 2012 PTCL: morphology and biology Chairmen: B. Falini, M. Paulli 8.30 a.m. 8.50 a.m. 9.10 a.m. PTCL-NOS: Histology S. Pileri Molecular genotyping H.K. Muller-Hermelink Gene expression profiling P.P. Piccaluga 9.30 a.m. AITL P. Gaulard 9.50 a.m. ALCL L. Lamant 10.10 a.m. Coffee break PTCL: monoclonal antibodies and single agent treatments Chairmen: U. Vitolo, E. Zucca 10.30 a.m. Pralatrexate S.M. Horwitz 10.45 a.m. Alemtuzumab L. Trumper 11.00 a.m. Belinostat F. Foss 11.15 a.m. Romidepsin B. Coiffier 11.30 a.m. Lenalidomide P.L. Zinzani 11.45 a.m. Bortezomib W.S. Kim 12.00 a.m. Aplidin E. Zucca 12.15 a.m. Brentuximab Vedotin B. Pro 12.30 a.m. Denileukin Diftitox F. Foss 12.45 a.m. Asparaginase A. Jaccard 1.00 p.m. Tipifarnib T. Witzig 1.15 p.m. Tirosin-Kinasi inhibitors J. M. Vose 1.30 p.m. Lunch CTCL: morphology and biology Chairmen: E. Berti, S. Pileri 2.30 p.m. 2.50 p.m. 3.10 p.m. Histology M. Santucci Gene expression profiling S. Whittaker Unusual clinicopathologic variants of cutaneous T-cell lymphoma L. Cerroni
2.30 p.m. 2.50 p.m. 3.10 p.m. Histology M. Santucci Gene expression profiling S. Whittaker Unusual clinicopathologic variants of cutaneous T-cell lymphoma L. Cerroni CTCL: innovative treatments Chairmen: N. Pimpinelli, R. Willemze 3.30 p.m. Romidepsin S. Bates 3.45 p.m. KW-0761 M. Duvic 4.00 p.m. Lenalidomide S. Rosen 4.15 p.m. Brentuximab Vedotin Y.H. Kim 4.30 p.m. Forodesine M. Duvic 4.45 p.m. Vorinostat S. Bates 5.00 p.m. Panobinostat H.M. Prince 5.15 p.m. Bexarotene P. Quaglino 5.30 p.m. JNJ-26481585 U. Banerji 5.45 p.m. SGN-30 L. Pinter-Brown 6.00 p.m. Pralatrexate S.M. Horwitz 6.15 p.m. Gemcitabine/Pentostatin C.E. Dearden 6.30 p.m. Pegylated liposomal doxorubicin R. Dummer
Wednesday September 19, 2012 T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma Chairmen: M. Gobbi, G. Pizzolo 8.30 a.m. 8.50 a.m. 9.10 a.m. 9.30 a.m. Biology A. Ferrando Therapy: Pediatrics A. Pession Adults G. Martinelli Nelarabine: a new drug D. Kisor 9.45 a.m. Coffee Break 10.00 a.m. 10.20 a.m. 10.40 a.m. 11.00 a.m. 11.20 a.m. 11.40 a.m. 12.00 a.m. 12.20 a.m. From mouse models to prognostic factors Chairmen: G. Gaidano, F. Lauria Moving preclinical pharmacology to the patient O.A. O Connor Animals models of T-cell lymphomas G. Inghirami Prognostic factors: PTCL M. Federico CTCL Y.H. Kim Transplant setting Chairman: A. Rambaldi High dose therapy in PTCL F. D Amore Allotransplant in PTCL P. Corradini High dose therapy and allostransplant in CTCL F. Onida Closing remarks
GENERAL INFORMATION MEETING VENUE Royal Hotel Carlton Via Montebello, 8-40121 Bologna, Italy Phone +39 051 249361 - Fax +39 051 249724 http://www.monrifhotels.it/royalcarltonhotel HOW TO GET THERE By car: from the motorway, turn into the ring road ("Tangenziale") - Exit 7 Fiera and follow direction city center and railway station. By taxi: from the airport about 30 minutes. By bus: bus 91 and Aerobus from the airport. By train: from the railway station walking distance. OFFICIAL LANGUAGE English REGISTRATION FEE Euro 400,00 (Italian VAT included) The registration fee includes: Conference kit Partecipation in the scientific sessions Attendance Certificate Coffee breaks Lunch REGISTRATION Registrations can only be accepted and confirmed after the registration form and fee have been received by the Organizing Secretariat, Studio E.R. Congressi. All payments must be done in Euro net of all bank charges and made out to Studio E.R. Congressi S.r.l. Please pay by: * Bank transfer made out to Studio E.R. Congressi S.r.l. CASSA DI RISPARMIO DI CESENA - Agenzia n 29, Largo Caduti del Lavoro 1/A, Bologna Swift code: CECRIT 2C - Iban code: IT49L 06120 02400 CC0290002596 * Credit Card Please send a copy of the bank transfer with the registration form. In case of written cancellation before July 20th, 2011, 80% of the registration fee will be refunded. HOTEL AND TRAVEL AGENCY FOR ATTENDEES Viaggi Salvadori Srl Via Ugo Bassi, 13-40121 Bologna Italy Phone +39 051 263281 - Fax +39 051 224426 E-mail: tcell@viaggisalvadori.it ORGANIZING SECRETARIAT Studio E.R. Congressi - Triumph Group Via Marconi, 36-40122 Bologna, Italy Phone +39 051 4210559 - Fax +39 051 4210174 e-mail: ercongressi@triumphgroup.it www.ercongressi.it
SCIENTIFIC INFORMATION SCIENTIFIC COORDINATOR Pier Luigi Zinzani Dipartimento di Ematologia e Scienze Oncologiche Lorenzo e Ariosto Seràgnoli Via Massarenti, 9-40138 Bologna, Italy Phone +39 051 6363680 - Fax +39 051 6364037 e-mail: pierluigi.zinzani@unibo.it SLIDES Slides must be in English. Computer videoprojection will be available in Power Point. Other requirements should be communicated to the Organizing Secretariat as soon as possible. Slides should be handed to the slide center one hour before the beginning of the session and collected at the end. BADGE All registered participants, speakers and exhibitors will be given a badge which they must wear to be admitted to the scientific sessions. ATTENDANCE CERTIFICATE A certificate will be given to all participants at the end of the Meeting. CME Application for Italian and European CME credits will be made. CHANGES Parts of the program may be changed if necessary.